Increasing the use of outpatient IV antibiotic therapy in BC: Do incentives work?
Data access has been granted for a study to evaluate the usage of outpatient intravenous (IV) antibiotic therapy in BC, and to assess the effectiveness of the G33655 fee code in expanding the use of outpatient IV antibiotic therapy.
Data access has been approved for research to examine the relationship between injury, opioid prescribing and overdose and overdose death, to identify potential strategies for early intervention and prevent illicit drug overdoses in private residences in the Fraser Health Authority region.
Data access has been approved for a study aiming to develop a ‘smart discharge tool’ to help identify child patients from northern BC communities who are at high risk for hospital re-admission.